Literature DB >> 12740357

Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency.

T Ichikawa, K Hamasaki, H Ishikawa, E Ejima, K Eguchi, K Nakao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12740357      PMCID： PMC1773673          DOI： 10.1136/gut.52.6.914

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Tamoxifen-induced fatty liver in patients with breast cancer.

Authors:  Y Ogawa; Y Murata; A Nishioka; T Inomata; S Yoshida
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

2.  Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.

Authors:  I R Willner; B Waters; S R Patil; A Reuben; J Morelli; C A Riely
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

Review 3.  Growth hormone and the metabolic syndrome.

Authors:  G Johannsson; B A Bengtsson
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

4.  Liver pathology and the metabolic syndrome X in severe obesity.

Authors:  P Marceau; S Biron; F S Hould; S Marceau; S Simard; S N Thung; J G Kral
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958
  4 in total
  36 in total

1.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.

Authors:  Camella G Wilson; Jennifer L Tran; Derek M Erion; Nicholas B Vera; Maria Febbraio; Ethan J Weiss
Journal:  Endocrinology       Date:  2015-12-09       Impact factor: 4.736

3.  Adipocyte-Specific GH Receptor-Null (AdGHRKO) Mice Have Enhanced Insulin Sensitivity With Reduced Liver Triglycerides.

Authors:  Edward O List; Darlene E Berryman; Mathew Buchman; Caitlin Parker; Kevin Funk; Stephen Bell; Silvana Duran-Ortiz; Yanrong Qian; Jonathan A Young; Cody Wilson; Julie Slyby; Savannah McKenna; Elizabeth A Jensen; John J Kopchick
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

4.  Esterase 1 is a novel transcriptional repressor of growth hormone receptor gene expression: a unique noncatalytic role for a carboxyesterase protein.

Authors:  Jinhong Sun; P Anil Kumar; Jamuna Thimmarayappa; Natinder Saini; Pooja Goel; Travis Maures; Chunxia Lu; Ram K Menon
Journal:  Mol Endocrinol       Date:  2011-06-09

5.  Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Authors:  Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Hamasaki; Ryuji Furukawa; Shotarou Tsuruta; Yasuo Ueda; Naota Taura; Hidetaka Shibata; Masumi Fujimoto; Kan Toriyama; Katsumi Eguchi
Journal:  Hepatol Int       Date:  2007-06-01       Impact factor: 6.047

Review 6.  Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

7.  Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.

Authors:  Shauna S Runchey; Edward J Boyko; George N Ioannou; Kristina M Utzschneider
Journal:  J Gastroenterol Hepatol       Date:  2014-03       Impact factor: 4.029

8.  Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease.

Authors:  Sherry Zhang; Chunxia Lu; Arun K Das; Anil K Pasupulati; Ram K Menon
Journal:  Growth Horm IGF Res       Date:  2018-10-04       Impact factor: 2.372

9.  [Non-alcoholic steatohepatitis and cirrhosis in young adult patients with hypothalamic-pituitary dysfunction].

Authors:  D Goltz; K Schötta; H Zhou; H-P Fischer
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

Review 10.  Endocrine and liver interaction: the role of endocrine pathways in NASH.

Authors:  Paola Loria; Lucia Carulli; Marco Bertolotti; Amedeo Lonardo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.